Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 16/20 | 0.52 |
| ▸ | ALK | Q9UM73 | 4/20 | 0.46 |
| ▸ | INSR | P06213 | 1/20 | 0.46 |
| ▸ | IGF1R | P08069 | 1/20 | 0.46 |
| ▸ | ROS1 | P08922 | 2/20 | 0.46 |
| ▸ | FLT3 | P36888 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26906835 | 1.00 | EGFR (0.52) | EGFRALKINSRIGF1RROS1 | |
| SCHEMBL26906770 | 0.92 | EGFR (0.49) | EGFR | |
| SCHEMBL30692634 | 0.91 | EGFR (0.58) | EGFRALKINSRIGF1RROS1 | |
| SCHEMBL26906712 | 0.91 | EGFR (0.58) | EGFRALKINSRIGF1RROS1 | |
| SCHEMBL26906761 | 0.84 | EGFR (0.66) | EGFRALKINSRIGF1RROS1 | |
| SCHEMBL29904687 | 0.84 | EGFR (0.53) | EGFRALKINSRIGF1R | |
| SCHEMBL26906574 | 0.84 | EGFR (0.53) | EGFRALKINSRIGF1R | |
| SCHEMBL26906904 | 0.83 | EGFR (0.60) | EGFRALKINSRIGF1R | |
| SCHEMBL30860293 | 0.83 | EGFR (0.60) | EGFRALKINSRIGF1R | |
| SCHEMBL26906519 | 0.82 | EGFR (0.77) | EGFRALKINSRIGF1RROS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022211573-A1 | PYRIMIDINE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME | 주식회사 테라펙스 | 2022-10-06 | — | — | WO | claimed |
| WO-2022211573-A1 | PYRIMIDINE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME | 주식회사 테라펙스 | 2022-10-06 | — | — | WO | disclosed |